AztraZeneca AB v. Mylan Pharms. Inc.: Claim Construction of a Percentage Term Guided by …

et al. (“Mylan”) for infringement of all claims of U.S. Patent Nos. 7,759,328; 8,143,239; and 8,575,137 (collectively, the “asserted patents”) …